PCM
GH icon

Palisade Capital Management’s Guardant Health GH Stock Holding History

Palisade Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,250
Closed -$410K – 432
2019
Q4 		$410K Sell
5,250
-500
-9% -$36K 0.01% 365
2019
Q3 		$367K Buy
+5,750
New +$507K 0.01% 377

Other funds holding GH

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Palisade Capital Management's GH Position: Q1 2020 in Review

Palisade Capital Management sold out of Guardant Health (GH) in Q1 2020, closing a stake of 5,250 shares — an estimated $410K sold.

Palisade Capital Management first reported a position in GH in Q3 2019 and held it in 2 quarters. The position peaked at $410K in Q4 2019. 288 funds tracked by Wall St. Rank hold GH as of Q1 2020.

  • Palisade Capital Management reported no remaining Guardant Health position as of Q1 2020 after selling out during the quarter.
  • Palisade Capital Management sold 5,250 Guardant Health shares in Q1 2020, an estimated $410K.
  • Palisade Capital Management first reported a position in Guardant Health in Q3 2019 and held it in 2 quarters.
  • Palisade Capital Management's Guardant Health position peaked at $410K in Q4 2019.
  • 288 funds tracked by Wall St. Rank held Guardant Health as of Q1 2020.

Based on Palisade Capital Management's 13F filing for Q1 2020, filed 13 May 2020.